UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Comprehensive identification and comparative analysis of protein-unbound Amadori products in powdered infant formulas: Integrating untargeted and targeted metabolomics with LC-Q-Orbitrap-MS/MS Journal article
Dong, Ying, Wang, Heng, Li, Guodong, Wang, Chuyang, Han, Liqiao, Wan, Zemin, Yan, Jun, Zhang, Qiaoxuan, Zhan, Min, Ke, Peifeng, Lin, Haibiao, Wu, Xinzhong, Huang, Xianzhang, Zhang, Pengwei. Comprehensive identification and comparative analysis of protein-unbound Amadori products in powdered infant formulas: Integrating untargeted and targeted metabolomics with LC-Q-Orbitrap-MS/MS[J]. LWT, 2024, 213, 117022.
Authors:  Dong, Ying;  Wang, Heng;  Li, Guodong;  Wang, Chuyang;  Han, Liqiao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.0/6.0 | Submit date:2024/12/05
Maillard Reaction  Amadori Compounds  Glycation  Lc-ms/ms  Neutral Loss  Free Amadori Products  
Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells Journal article
Miao, Lingchao, Zhang, Haolin, Cheong, Meng Sam, Zhong Ruting, Garcia-Oliveira, Paula, Prieto, Miguel A, Cheng, Ka-Wing, Wang, Mingfu, Cao, Hui, Nie, Shaoping, Simal-Gandara, Jesus, Cheang, Wai San, Xiao, Jianbo. Anti-diabetic potential of apigenin, luteolin, and baicalein via partially activating PI3K/Akt/Glut-4 signaling pathways in insulin-resistant HepG2 cells[J]. Food Science and Human Wellness, 2023, 12(6), 1991-2000.
Authors:  Miao, Lingchao;  Zhang, Haolin;  Cheong, Meng Sam;  Zhong Ruting;  Garcia-Oliveira, Paula; et al.
Favorite | TC[WOS]:23 TC[Scopus]:21  IF:5.6/6.8 | Submit date:2022/08/11
Apigenin  Luteolin  Baicalein  Insulin-resistant Hepg2 Cells  Signaling Pathway  Reactive Oxygen Species (Ros)  Advanced Glycation End-products (Ages)  Glycogen Synthase Kinase (Gsk-3β)  Glucose Transporter Protein 4 (Glut4)  
Pitfalls and Solutions in Mass Spectrometry-Based Identification of Protein Glycation Journal article
Ma, Wendong, Ang, Irene Ling, Lei, Kate Man Kei, Lam, Melody Man Ting, Zhang, Pengwei, Poon, Terence Chuen Wai. Pitfalls and Solutions in Mass Spectrometry-Based Identification of Protein Glycation[J]. Analytical Chemistry, 2023, 95(3), 1829–1837.
Authors:  Ma, Wendong;  Ang, Irene Ling;  Lei, Kate Man Kei;  Lam, Melody Man Ting;  Zhang, Pengwei; et al.
Adobe PDF | Favorite | TC[WOS]:2 TC[Scopus]:1  IF:6.7/6.5 | Submit date:2023/08/31
Mass Spectrometry  Protein Glycation  Advanced Glycation End Product  Proteomics  Analytical Method  
Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer’s disease treatment by anti-neuroinflammation and neuroprotection Journal article
He, Xueqin, Wang, Xiaorong, Yang, Lianyi, Yang, Zhihang, Yu, Wenqi, Wang, Yazhen, Liu, Rui, Chen, Meiwan, Gao, Huile. Intelligent lesion blood-brain barrier targeting nano-missiles for Alzheimer’s disease treatment by anti-neuroinflammation and neuroprotection[J]. Acta Pharmaceutica Sinica B, 2022, 12(4), 1987-1999.
Authors:  He, Xueqin;  Wang, Xiaorong;  Yang, Lianyi;  Yang, Zhihang;  Yu, Wenqi; et al.
Favorite | TC[WOS]:41 TC[Scopus]:45  IF:14.7/14.1 | Submit date:2022/08/29
Receptor For Advanced Glycation End Products  Ros-responsive  Blood‒brain Barrier Transcytosis  Alzheimer's Disease  Drug Combination  Anti-neuroinflammation  Neuroprotection  Nano Drug Delivery System  
Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection Journal article
He, Xueqin, Wang, Xiaorong, Yang, Lianyi, Yang, Zhihang, Yu, Wenqi, Wang, Yazhen, Liu, Rui, Chen, Meiwan, Gao, Huile. Intelligent lesion blood–brain barrier targeting nano-missiles for Alzheimer's disease treatment by anti-neuroinflammation and neuroprotection[J]. Acta Pharmaceutica Sinica B, 2022, 12(4), 1987-1999.
Authors:  He, Xueqin;  Wang, Xiaorong;  Yang, Lianyi;  Yang, Zhihang;  Yu, Wenqi; et al.
Favorite | TC[WOS]:41 TC[Scopus]:45  IF:14.7/14.1 | Submit date:2022/05/13
Alzheimer's Disease  Anti-neuroinflammation  Blood‒brain Barrier Transcytosis  Drug Combination  Nano Drug Delivery System  Neuroprotection  Receptor For Advanced Glycation End Products  Ros-responsive  
Advanced glycation end products in chinese medicine mediated aging diseases: A review Journal article
Zhang,Wenqian, Zhao,Tingting, Zhao,Yonghua, Gui,Dingkun, Xu,Youhua. Advanced glycation end products in chinese medicine mediated aging diseases: A review[J]. Current Vascular Pharmacology, 2020, 18(4), 322-333.
Authors:  Zhang,Wenqian;  Zhao,Tingting;  Zhao,Yonghua;  Gui,Dingkun;  Xu,Youhua
Favorite | TC[WOS]:7 TC[Scopus]:8  IF:2.8/3.5 | Submit date:2021/03/02
Advanced Glycation End Products  Aging  Alzheimer’s Disease  Chinese Medicines  Diabetes  Vascular Diseases  
Phloretin and its methylglyoxal adduct: Implications against advanced glycation end products-induced inflammation in endothelial cells Journal article
Zhou, Qian, Gong, Jun, Wang, Mingfu. Phloretin and its methylglyoxal adduct: Implications against advanced glycation end products-induced inflammation in endothelial cells[J]. Food and Chemical Toxicology, 2019, 129, 291-300.
Authors:  Zhou, Qian;  Gong, Jun;  Wang, Mingfu
Favorite | TC[WOS]:40 TC[Scopus]:45  IF:3.9/4.5 | Submit date:2022/05/17
Advanced Glycation End Products  Inflammation  Methylglyoxal  Phloretin-methylglyoxal Adduct  
Inhibition of resveratrol glucosides (REs) on advanced glycation endproducts (AGEs) formation: inhibitory mechanism and structure-activity relationship Journal article
Liu, Minzhuo, Tang, Fen, Liu, Qi, Xiao, Jianbo, Cao, Hui, Chen, Xiaoqing. Inhibition of resveratrol glucosides (REs) on advanced glycation endproducts (AGEs) formation: inhibitory mechanism and structure-activity relationship[J]. Natural Product Research, 2018, 34(17), 2490-2494.
Authors:  Liu, Minzhuo;  Tang, Fen;  Liu, Qi;  Xiao, Jianbo;  Cao, Hui; et al.
Favorite | TC[WOS]:17 TC[Scopus]:15  IF:1.9/2.1 | Submit date:2021/12/06
Advanced Glycation Endproducts  Antiglycation Mechanism  Resveratrol Glucosides  Structure-activity Relationship